Analytics & Prefomulation

This Analytics & Preformulation Pipeline stream explores sets out to investigate the intersection of predictive modeling, formulation science, and analytical innovation in the early development of novel biologics. As the complexity and diversity of biotherapeutic modalities expand, the integration of artificial intelligence, strategic formulation, and robust analytical platforms has become essential for accelerating development timelines and ensuring clinical success. The AI/ML Approaches in Immunogenicity Prediction will showcase cutting-edge tools for predicting specific immune responses in early-stage development.  The Analytical Strategies for Novel Biologics conference will explore the evolving analytical landscape for next-generation biologics, including modalities of bispecifics, ADCs, fusion proteins, peptides and RNA-based therapeutics; and the Biotherapeutics Aggregation and Preformulation Strategies conference will focus  focuses on predicting and mitigating aggregation risk using strategies for early aggregation screening and biophysical characterization while assessing preformulation challenges for novel modalities and high concentration biologics.